LFG
DNA icon

Larson Financial Group’s Ginkgo Bioworks DNA Stock Holding History

Larson Financial Group’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-181
Closed -$2.64K – 3512
2025
Q3 		$2.64K Buy
181
+175
+2,917% +$2.09K ﹤0.01% 2596
2025
Q2 		$68 Hold
6
– – ﹤0.01% 3208
2025
Q1 		$34 Hold
6
– – ﹤0.01% 3014
2024
Q4 		$59 Sell
6
-75
-93% -$643 ﹤0.01% 2679
2024
Q3 		$660 Buy
81
+25
+45% +$251 ﹤0.01% 2069
2024
Q2 		$752 Hold
56
– – ﹤0.01% 1765
2024
Q1 		$2.61K Hold
56
– – ﹤0.01% 1321
2023
Q4 		$3.8K Buy
56
+50
+833% +$3.06K ﹤0.01% 1252
2023
Q3 		$453 Buy
+6
New +$480 ﹤0.01% 1583

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return